PDAC
Clinical trials for PDAC explained in plain language.
Never miss a new study
Get alerted when new PDAC trials appear
Sign up with your email to follow new studies for PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers with RAS mutations
Disease control Not yet recruitingThis study tests a new drug called GFH276 in people with advanced cancers that have a specific gene change (RAS mutation). The cancers include pancreatic, lung, and colorectal cancer. The goal is to find a safe dose and see if the drug can shrink tumors. About 450 adults aged 18-…
Matched conditions: PDAC
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for pancreatic cancer: experimental drug combo enters large trial
Disease control Not yet recruitingThis study tests a new drug, telisotuzumab adizutecan, combined with standard chemotherapy (FOLFOX) in people with metastatic pancreatic cancer that has spread. About 900 adults will receive either the new combination or standard care. The goal is to see if the new treatment shri…
Matched conditions: PDAC
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 14, 2026 12:03 UTC